Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease

Journal of Neural Transmission

Volumn 103, Issue 7, 1996, Pages 843-849

  Takakubo, F ^a   Yamamoto, M ^b   Ogawa, N ^c   Yamashita, Y ^d   Mizuno, Y ^e   Kondo, I ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MATSUYAMA RED CROSS HOSPITAL   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

Association; Cytochrome P450IA1 gene (CYPIA1); Genetic risk factor; Parkinson's disease (PD)

Indexed keywords

AROMATIC HYDROCARBON; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLLUTANT; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0029801364     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01273362     Document Type: Article

References (23)

1. Catteau A, Douriez E, Beaune P, Poisson N, Bonaiti-Pellie C, Laurent P (1995) Genetic polymorphism of induction of CYPIA1 (EROD) activity. Pharmacogenetics 5: 110-119
2. Clarke PBS, Hommer DW, Pert A, Skirboll LR (1985) Electrophysiological action of nicotine on substantia nigra single units. Br J Pharmacol 85: 827-835
3. Farin FM, Omiecinski CJ (1993) Regionspecific expression of cytochrome P450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health 40: 323-341
4. Ghersi-Egea J-F, Perrin R, Leininger-Muller B, Grassiot M-C, Jeandel C, Floquet J, Cuny G, Siest G, Minn A (1993) Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45: 647-658
5. Golbe LI, Cody RA, Duvoisin RC (1986) Smoking and Parkinson's disease. Search for a dose-response relationship. Arch Neurol 43: 774-778
6. Gonzalez FJ (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288
7. Gonzalez FJ, Gelboin HV (1994) Role of human cytochrome P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26: 165-183
8. Hayashi J-I, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme-binding region of the human cytochrome P450 A1 gene. J Biochem 110: 407-411
9. Kadlubar FF (1994) Biochemical individuality and its implications for drug and carcinogen metabolism. Recent insights from acetyltransferase and cytochrome P450IA2 phenotyping and genotyping in humans. Drug Metab Dispos 26: 37-46
10. Kondo K, Kurland LT, Schull WJ (1973) Parkinson's disease, genetic analysis and evidence of a multifactorial etiology. Mayo Clin Proc 48: 465-475
11. 2+-mediated endonuclease activation. Science 242: 256-259
12. McKusick VA (1994) Cyrochrome P-450, Family I, P3-450 [CYPIA2; dioxin-inducible P3-450 phenacetin metabolism, defect in induced phenacetin o-deethylase, deficiency of induced] in Medelian inheritance in man. The Johns Hopkins University Press, Baltimore London, p 401, I
13. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P450. Cancer Res 50: 3367-3376
14. Morens DM, Grandinetti A, Reed D, White LR, Ross GW (1995) Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45: 1041-1051
15. Nebert DW, Petersen DD, Puga A (1991) Human AH locus polymorphism and cancer: inducibility of CYPIA1 and other genes by combustion products and dioxin. Pharmacogenetics 1: 68-78
16. Okada T, Kawashima K, Fukushi S, Minakuchi T, Nishimura S (1994) Association between a cytochrome P450 CYPIA1 genotype and incidence of lung cancer. Pharmacogenetics 4: 333-340
17. Paulson GW (1992) Addiction to nicotine is due to high intrinsic levels of dopamine. Med Hypotheses 38: 206-207
18. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW (1991) Human CYPIA1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48: 720-725
19. Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH (1985) Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA 4: 395-400
20. Schwart RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220: 214-216
21. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339: 1375-1377
22. Wedlund PJ, Kimura S, Gonzalez FJ, Nebert DW (1994) I462V mutation in the human CYPIA1 gene: lack of correlation with either Msp I 1.9kb (M2) allele or CYPIA1 inducibility in a three-generation family of east Mediterranean descent. Pharmacogenetics 4: 21-26
23. Wright SC, Zhong J, Zheng H, Larrick JW (1993) Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J 7: 1045-1051